ARRAY BIOPHARMA
   
 

Welcome to Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas.

Latest News and Press Releases:
5/16/2012 Array BioPharma Announces Clinical Data Presentations at the 2012 ASCO Annual Meeting
5/14/2012 Array BioPharma and Genentech's Strategic Alliance Voted Breakthrough Alliance of 2012
4/30/2012 Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2012
4/30/2012 Array BioPharma Names Liam Ratcliffe, M.D., Ph.D., to Board of Directors
 
Email this page
Printer friendly version
   
ASCO Annual Meeting